Onyx BiotecNSE:ONYX -0.24%25 Days Payable is 114.18 as of Mar. 2026, which is 8% above its 10-year median of 105.74. GuruFocus rates NSE:ONYX with a GF Score™ of 25/100. The stock has 6 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Onyx Biotec ranks better than 70.06% on this metric.
The historical rank and industry rank for Onyx Biotec's Days Payable or its related term are showing as below:
NSE:ONYX'
s Days Payable Range Over the Past 10 Years
Min: 59.4 Med: 105.74 Max: 142.32
Current: 114.66
During the past 5 years, Onyx Biotec's highest Days Payable was 142.32. The lowest was 59.40. And the median was 105.74.
NSE:ONYX's Days Payable is ranked better than 70.06% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs NSE:ONYX: 114.66
Onyx Biotec's Days Payable
declined
from Mar. 2025 (148.68) to Mar. 2026 (114.18).
It may suggest that Onyx Biotecaccelerated paying its suppliers.
Onyx Biotec Days Payable Related Terms
Onyx Biotec Days Payable Historical Data
* Premium members only.
The historical data trend for Onyx Biotec's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ONYX vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Onyx Biotec's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Onyx Biotec Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Onyx Biotec's Days Payable distribution charts can be found below:
* The bar in red indicates where Onyx Biotec's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Onyx Biotec's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Onyx Biotec (NSE:ONYX) has a Days Payable of 114.18 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Onyx Biotec and its competitors. This is near median its historical median of 105.74. Over the past decade, Onyx Biotec's Days Payable has ranged from 59.40 to 142.32. According to the industry distribution chart, Onyx Biotec ranks #238 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 29.9%.
Is Onyx Biotec's Days Payable too high?
Onyx Biotec's current Days Payable of 114.18 is near median its 10-year median of 105.74. Over the past 10 years, this metric has ranged from a low of 59.40 to a high of 142.32. The Medical Devices & Instruments industry median Days Payable is 68.07. Onyx Biotec's value of 114.18 is 67.7% above this industry median. Based on the distribution chart, Onyx Biotec ranks #238 out of 795 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Onyx Biotec has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Onyx Biotec's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Onyx Biotec ranks #238 out of 795 companies for Days Payable. This puts Onyx Biotec in the upper half of its industry. The industry median Days Payable is 68.07. Onyx Biotec's value of 114.18 is 67.7% above this benchmark. Historically, Onyx Biotec's own Days Payable has ranged from 59.40 to 142.32 over the past decade. While the company's 10-year median is 105.74 vs. the industry median of 68.07, Onyx Biotec has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Onyx Biotec's current Days Payable of 114.18 is 67.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Onyx Biotec and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Onyx Biotec's current Days Payable is 114.18, which is near median its own 10-year median of 105.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onyx Biotec stock overvalued right now?
Onyx Biotec (NSE:ONYX) has a current Days Payable of 114.18. The current Days Payable is 114.18, which is near median its 10-year median of 105.74 and 67.7% above the Medical Devices & Instruments industry median of 68.07. Onyx Biotec's overall GF Score™ is 25/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Onyx Biotec (NSE:ONYX), the current Days Payable is 114.18 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Onyx Biotec Ltd is engaged in healthcare segment and offering Sterile Pharmaceutical products ,and acts as a pharmaceutical contract manufacturer. It offering products such as Sterile Water for Injections, Dry Powder Injections and Dry Syrup for India and overseas. Key revenue is generated from Sterile Water for Injections .
25GF Score
Get the complete analysis for NSE:ONYX
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ONYX has been successfully added to your 